Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.440, 2003-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab eases symptoms, economic burden of RA
Inpharma, Vol. 1, Iss. 1415, 2003-01 ,pp. :
Glycaemic control eases economic burden of diabetes mellitus
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 424, 2003-01 ,pp. :
Adalimumab adds to methotrexate efficacy in RA
Inpharma, Vol. 1, Iss. 1645, 2008-01 ,pp. :
Tocilizumab dominates adalimumab for severe RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 669, 2013-01 ,pp. :
Adolescent, adult vax against pertussis eases burden in the US
Inpharma, Vol. 1, Iss. 1526, 2006-01 ,pp. :